Antiretroviral therapy coverage in Syrian Arab Republic
Syrian Arab Republic: Antiretroviral therapy coverage was 55.0% in 2024. ◆ Volatile
Antiretroviral therapy coverage in Syrian Arab Republic, 2000–2024
Source: UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS). Measured in % of people living with HIV.
Analysis
The most recent figure for antiretroviral therapy coverage in Syrian Arab Republic is 55.0%, measured in 2024. That is the highest value across all 25 years on record.
Compared with earlier readings it is up 1.9% on the previous year and up 175.0% over ten years.
Over the whole period, antiretroviral therapy coverage in Syrian Arab Republic peaked at 55.0% in 2024 and was at its lowest, 0.0%, in 2000.
That places Syrian Arab Republic 112th out of 143 countries with data for 2024, putting it in the bottom quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Antiretroviral therapy coverage in Syrian Arab Republic, year by year
| Year | % of people living with HIV | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 1.0% | — |
| 2004 | 4.0% | +300.0% |
| 2005 | 4.0% | +0.0% |
| 2006 | 4.0% | +0.0% |
| 2007 | 5.0% | +25.0% |
| 2008 | 5.0% | +0.0% |
| 2009 | 7.0% | +40.0% |
| 2010 | 9.0% | +28.6% |
| 2011 | 12.0% | +33.3% |
| 2012 | 15.0% | +25.0% |
| 2013 | 17.0% | +13.3% |
| 2014 | 20.0% | +17.6% |
| 2015 | 21.0% | +5.0% |
| 2016 | 23.0% | +9.5% |
| 2017 | 29.0% | +26.1% |
| 2018 | 35.0% | +20.7% |
| 2019 | 42.0% | +20.0% |
| 2020 | 44.0% | +4.8% |
| 2021 | 45.0% | +2.3% |
| 2022 | 46.0% | +2.2% |
| 2023 | 54.0% | +17.4% |
| 2024 | 55.0% | +1.9% |
Syrian Arab Republic compared with similar countries
- Syrian Arab Republic's 55.0% is below the median for low income countries, which is 69.5%, 79% of the median. (24 countries reporting)
- Syrian Arab Republic's 55.0% is below the median for Middle East, North Africa, Afghanistan & Pakistan, which is 59.5%, 92% of the median. (20 countries reporting)
Biggest year-on-year movements
Years where Antiretroviral therapy coverage in Syrian Arab Republic changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.
| Year | Change | From | To |
|---|---|---|---|
| 2004 | +300.0% | 1.0% | 4.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 3.0% | 0.0% | 7.0% | 10 |
| 2010s | 22.3% | 9.0% | 42.0% | 10 |
| 2020s | 48.8% | 44.0% | 55.0% | 5 |
Countries ranked near Syrian Arab Republic
- 109 North Macedonia 59.0% compare
- 110 Paraguay 58.0% compare
- 111 Venezuela, Bolivarian Republic of 57.0% compare
- 112 Bahrain 55.0% compare
- 114 Jamaica 54.0% compare
- 115 Kyrgyzstan 53.0% compare
- 115 Republic of Moldova 53.0% compare
More health data for Syrian Arab Republic
- Un projection of annual infant deaths, annual growth rate -2.1 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.8632 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,122 deaths per 1,000 people (2090)
- Number of infants who die before age 1 1,491 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 2 (2025)
- Population ages 00-04, female, annual growth rate 7.54 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2022)
- Population ages 00-04, female, per capita 0.0503 units per person (2025)
- Population ages 00-04, male, annual growth rate 7.65 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2022)
Frequently asked questions
- What is antiretroviral therapy coverage in Syrian Arab Republic?
- Antiretroviral therapy coverage in Syrian Arab Republic was 55.0% in 2024, according to UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS).
- What is the highest antiretroviral therapy coverage recorded in Syrian Arab Republic?
- The highest recorded value was 55.0% in 2024.
- What is the lowest antiretroviral therapy coverage recorded in Syrian Arab Republic?
- The lowest recorded value was 0.0% in 2000.
- How does Syrian Arab Republic rank for antiretroviral therapy coverage?
- Syrian Arab Republic ranks 112th out of 143 countries with data for 2024.
- Is antiretroviral therapy coverage rising or falling in Syrian Arab Republic?
- Over the last ten years it is up 175.0%. The long-run trend across the full record is volatile.
- Where does this Syrian Arab Republic data come from?
- The figures come from UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as part of Antiretroviral therapy coverage (% of people living with HIV). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Antiretroviral therapy coverage indicates the percentage of all people living with HIV who are receiving antiretroviral therapy.